New Jersey Healthcare Essential WoRker Outreach and Education Study - Testing Overlooked Occupations |
|
NJ HEROES TOO has concluded...
THANK YOU to all the partners that contributed to our SUCCESS!
|
|
Below are some publications, press releases, and peer-reviewed papers that reflect what we have learned from the NJ HEROES TOO project. |
|
NJ ACTS 4 Us! CONNECT is a publication of the New Jersey Alliance for Clinical & Translational Sciences (NJ ACTS) Community Engagement Core, supported by the NJ ACTS CTSA grant UL1TR003017.
Study reveals the experience of support health care workers from underserved communities during COVID-19, News Medical Life Science, 01/18/2022. To learn more, click here.
How COVID-19 has affected Black and Latinx healthcare workers, Chief Healthcare Executive, 01/20/2022. To learn more, click here.
Health care support workers have been essential yet unappreciated in pandemic, study says, NorthJersey.com, 01/24/2022. To learn more, click here.
Experiences of Black and Latinx health care workers in support roles during the COVID-19 pandemic: A qualitative study. Black and Latinx individuals, and in particular women, comprise an essential health care workforce often serving in support roles such as nursing assistants and dietary service staff. Compared to physicians and nurses, they are underpaid and potentially undervalued, yet play a critical role in health systems. This study examined the impact of the coronavirus disease 2019 (COVID-19) pandemic from the perspective of Black and Latinx health care workers in support roles. To learn more, click here.
Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing and Vaccines. Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. This paper aims to explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines.
To read the full paper on the JAMA Network Open, click here.
|
|
One-on-One Consultations
The CEC helps researchers obtain project-specific input from research, healthcare, community, and patient stakeholders to enhance research design, implementation, and dissemination.
|
|
Community Engagement Virtual Salons (CEVS)
CEVS bring researchers together with patients, community members, and health care stakeholders to actively participate in cross-talk. It provides a forum for generating research questions, identifying evidence gaps, and defining outcomes meaningful to patients.
If you're interested in working with us, click here to learn more.
To see a CEVS in action, click on the summary videos featured below.
|
|
The Diabetes LIFEMAP© & Social Determinants of Health (SDOH)
Dr. Shilpa Pai, Dr. David Bleich, and Carmen Wheeler
Rutgers University- Robert Wood Johnson Medical School
March 4rd, 2021
|
|
Click on the image above to view the video. |
|
Click on the image above to view the video. |
|
A Youth-Led Digital Education
Intervention to Improve Adult Blood Pressure
Sara Heinert, PhD
Assistant Professor & Associate Research Director
Department of Emergency Medicine
May 17th, 2021
|
|
|
|
If your research has benefited from one or more NJ ACTS resources, please remember to:
-
Cite our CTSA grant, UL1TR003017, KL2TR003018, or TL1TR003019 in any relevant publications, abstracts, chapters, and/or posters.
-
Submit your publications to PubMed Central (PMC) for compliance with the NIH Public Access Policy.
-
Share your research updates with us by sending an email to: njactscommunity@rwjms.rutgers.edu
|
|
PRINCETON - Coronavirus researcher Cameron Myhrvold is using ‘spectacular’ new technologies to seek and destroy viral pathogens
“I was really fascinated by viruses — how they could make us so sick, but they’re so simple, with so few genes,” Myhrvold said. “And I’ve always had an interest in technology, so I think it was inevitable that there would be a technology component to the work that I was doing.” In January 2021, Myhrvold joined the department of molecular biology as one of Princeton’s newest COVID-19 experts and part of a growing cohort of researchers who straddle the boundary between fundamental research and groundbreaking technological developments. To read the full story, click here.
|
|
NJIT - COVID-19 Vaccines Breathe Life into Research Done 20 Years Ago
Research conducted 20 years ago by a former NJIT dean is being put to new use in the COVID-19 vaccine from Pfizer-BioNTech. Barry Cohen, who was an associate dean of Ying Wu College of Computing, worked on the algorithm for bioengineering stable messenger RNA (mRNA), a key ingredient of the vaccine recently approved for emergency use by the U.S. Centers for Disease Control and the Food and Drug Administration. To read the full article, click here.
|
|
|
|
RUTGERS - Rutgers Microbiologists’ Research Subject of Feature-Length Documentary
The Invisible Extinction follows Martin Blaser and Maria Gloria Dominguez-Bello around the globe as they research damage to the human microbiome. To learn more, click here.
|
|
Community Spotlight
NJ HEROES TOO Partners
|
|
The NJ HEROES TOO project was co-created and co-design by our community and healthcare partners. In this issue of the CEC Quarterly Newsletter we conclude the spotlight of our 22 partners.
|
|
Sister2Sister
Sister2Sister, Inc. provides sanctuary, support, education, advocacy and administers breast cancer related programs for minority and underserved breast cancer survivors. Sister2Sister has provided years of breast health advocacy, education, and survivor support to the Central New Jersey Community. Sister2Sister is a 501©3 organization, a Breast Cancer Survivorship Organization. S2S was formed in January 2000 and serves as a critical resource for women battling the disease of breast cancer. Because underserved women have the highest breast cancer mortality rate, the organization’s mission is to alert communities, families, and the media to the devastation breast cancer causes in the underserved community. To learn more, click here.
|
|
The Bridge
The Bridge is an agency that works to provide multifaceted services designed to strengthen and support struggling young people and their families in the Irvington and Essex county area. Irvington is comprised of a diverse population of approximately 54,312 individuals with 87% identifying as Black and 9% identifying as Hispanic, many of whom fall below the poverty line. Since its inception in 1972, The Bridge has grown and successfully expanded to provide multifaceted services designed to strengthen and support struggling young people and their families, while always maintaining at its core, the initial, underlying goal of providing alternative choices for young people struggling with the results of poor decisions and untoward circumstances in their lives. To learn more, click here.
|
|
United Way of Greater Union County
For over 95 years, United Way of Greater Union County has been the preferred investment choice in improving the lives of children and families across Union County. Our mission is to improve lives and build strong communities by uniting individuals and organizations with the will, passion, expertise, and resources needed to solve problems. United Way of Greater Union County envisions a community where all children and families achieve their potential through education, income stability and health and family strengthening. Our commitment is to change the odds so that all children and their families, regardless of their circumstances, have the same chance to succeed in school and in life.
|
|
University Hospital
University Hospital is a separate, independent medical center in Newark, NJ with 519 licensed beds, a medical staff of more than 600 and more than 3,100 employees. It is the main academic teaching hospital affiliate of New Jersey Medical School. It is a regional resource for advanced care in a wide range of medical specialties. UH is home to northern New Jersey’s Level I Trauma Center and to specialty programs such as the Center for Liver Diseases and the Comprehensive Stroke Center. University Hospital ranks among the Best Hospitals in Northern New Jersey and the New York Metropolitan area, according to Best Hospitals rankings, published by U.S. News & World Report. University Hospital is also recognized for "high performance" in the clinical specialty of Nephrology. University Hospital was also recognized for its outstanding performance in the Leapfrog Hospital Recognition Program (LHRP). The survey rates each participating hospital on 18 Leapfrog standards and compares individual scores against state and national averages. UH ranked higher than the state and national averages on all three of the composite scores for quality, resource use and value. UH is the resource for NJMS investigators to conduct inpatient clinical trials. To learn more, click here.
|
|
Urban League of Union County
The Urban League of Union County Inc., founded in 1944, is a non-profit community-based organization in Elizabeth, New Jersey. We are one of 89 affiliates of the 107-year-old National Urban League located in New York City. The mission of the Urban League is to assist African Americans and other minority group members in the achievement of social and economic equality. We employ the tools and methods of social work and we intervene at all points in the social and economic structure where the interest of blacks and other minorities and the poor are at stake. We supply information on the minority population, conduct surveys, training programs, secure jobs, motivate youth, and provide essential services in education, housing, health and welfare. To learn more, click here.
|
|
Visiting Nurse Association
Established in 1912, the Visiting Nurse Association Health Group (VNAHG) is one of the nation's largest nonprofit, independent providers of home health, hospice, and community-based care serving New Jersey and midcentral Ohio. VNAHG is nationally accredited and is one of the only physician-led Visiting Nurse Association in the Country. It serves vulnerable populations such as at-risk children, the elderly, those with disabling and chronic illness, and people facing the end of life. It is dedicated to helping individuals and families achieve their best level of well-being by providing compassionate, coordinated, innovative care in their homes and communities. VNAHG also partners with organizations that are driving innovation and quality to achieve patient centered and cost-effective care. VNAHG’s mission to provide community health services, hospice care and home care in New Jersey is carried out through three institutes- Advanced Care Institute, Children & Family Health Institute, and Connected Health Institute. In 2016, VNA Health Group and RWJBarnabas Health formed a partnership to provide home health, hospice and private care services in Burlington, Essex, Hudson, Middlesex, Monmouth and Ocean Counties, operating as Barnabas Health Home Care and Hospice in Northern New Jersey and VNA of Central Jersey in Central and Southern New Jersey.
|
|
|
|
THANK YOU
TO OUR PARTNERS
|
|
|
|
|
The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for resources for individuals and community partners.
Check out our YouTube channel and blog to stay up to date with COVID-19 related news across the consortium.
|
|
As COVID evolves from pandemic to endemic in NJ, how will our lives change?
On March 4, 2020, a 32-year-old physician’s assistant from Fort Lee became the first person in New Jersey diagnosed with a disease that would claim more than 33,000 lives in the state, upend its economy, disrupt the education of millions of its children and sorely test its health care system. Now, two years later, New Jersey finally appears to be at a turning point in the COVID-19 pandemic. “I think we’ve passed the worst here,” said Dr. Brian L. Strom, chancellor of Rutgers Biomedical and Health Sciences.
|
|
|
|
|
Are masks key to living with COVID-19?
7 in 10 Americans believe COVID-19 is here to stay, and we need to “get on with our lives,” according to a Monmouth University Poll released in late January. Still, a topic that persists is masks — many strongly oppose mask mandates. In New Jersey, face coverings are no longer mandated in most indoor and outdoor settings. But cities like Newark are keeping their mask mandate in place until May. So is the mask-wearing debate coming to a close? It’s hard to tell.
|
|
Americans are stuck in unhealthy pandemic habits. Here's how to reboot.
After two years of pandemic life, people have learned to cope in ways that have become stubborn, unhealthy habits. But there are positive steps we can take to reset a healthy lifestyle.
|
|
|
COVID-19 Research Studies
|
|
The New Jersey Alliance for Clinical and Translational Science compiled resources for translating COVID-19 from bench to bedside. Visit the site.
To learn more about funding opportunities and innovation challenges to assist the academic research community in mitigating COVID-19, click here.
RBHS is actively engaged in scientific discovery surrounding COVID-19. To learn more about the RBHS COVID-19 clinical trials, click here.
Check out the COVID-19 related research across the consortium.
Rutgers Develops Rapid Screening Test for Omicron and Other Variants. A rapid test, which can be performed at laboratories experienced in COVID-19 testing, has been developed by researchers at Rutgers. The test can quickly detect clinical samples that contain the SARS-CoV-2 virus with signature mutations for each known variant of concern—namely, the Alpha, Beta/Gamma, Delta and Omicron variants—using special probes called “sloppy molecular beacons.” Read the full story.
Rutgers Leads National Collaboration to Study Long-Term Effects of COVID-19 in Children.
Rutgers Robert Wood Johnson Medical School (RWJMS) is projected to receive approximately $30 million, establishing a critical partnership with the larger National Institutes of Health–funded RECOVER Initiative to study long-term and delayed impacts of COVID-19 on children and lead a national collaboration with the potential to recruit from any state to investigate these outcomes. Impacts of infection with the virus SARS-CoV-2 that present or persist more than 30 days are collectively referred to as post-acute sequelae of COVID-19 (PASC). Among the first PASC recognized in children is Multisystem Inflammatory Syndrome in Children (MIS-C), a severe acute inflammatory illness, which typically begins unexpectedly about a month after the initial infection. Read the full story.
Rutgers–Camden Researcher Explains Omicron Variant’s Impact on the Stock Market. With the spread of the COVID-19 Omicron variant, investors across the country have seen substantial hits to their portfolios. Richard Michelfelder, a clinical associate professor in the Rutgers–Camden School of Business whose research focuses on regulation, utility stock prices and stock market risk, spoke to why coronavirus fears affect stock prices so universally and what investors should do to weather the storm. Read the full story.
Rutgers Expanding Enrollment of Participants for Pfizer COVID-19 Pediatric Vaccine Clinical Trial. Rutgers, a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children, is looking for participants for a third clinical trial on children ages 6 months to 4 years. “Children can get sick from COVID-19 and can spread the virus to others even if they are asymptomatic. While most children experience mild or no symptoms, some children can get severely ill and could have long-term effects,” said co-lead investigator Simon Li, an associate professor of pediatrics at Rutgers Robert Wood Johnson Medical School. “Maximizing COVID-19 vaccination in all age groups is important to stop the global progression of the disease. Vaccination will also help us feel safer about our children resuming school and daily activities.” The Pediatric Clinical Research Center at Rutgers Robert Wood Johnson Medical School in New Brunswick – the only clinical trial site in New Jersey — is one of the several clinical trial sites for Pfizer-BioNTech’s pediatric study. Read the full story.
|
|
We would like to share your resources with the community. Please email your information to njactscommunity@rjwms.rutgers.edu to contribute to our next Quarterly Newsletter issue.
|
|
Research Resources Workshop Wednesday (R2W2)
Every 2nd Wednesday 4-5pm
The Office of the Vice-Chancellor for Academic Affairs and Research announced their 2021 R2W2 Series, featuring shared resource core facilities available to Rutgers researchers. Learn more about these events here.
|
|
Continuing Education Opportunities |
|
Free NIH Seminars for Clinical Researchers
Sex and Gender in Research
Interest in sex and gender in research—and resources to help investigators—is growing. In the 5 years since NIH enacted its pioneering Policy on Sex as a Biological Variable (SABV) there has been a lot of activity, including increased attention on sex differences and influences and many questions and requests for assistance.
|
|
We would like to share your events with the community. Please email your event details to njactscommunity@rjwms.rutgers.edu to contribute to our next Quarterly Newsletter issue.
|
|
New Jersey Alliance for Clinical and Translational Science
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
You are receiving this newsletter because you are a member of NJ ACTS or have signed up to receive our emails.
To add a subscriber, please click here.
Send story ideas, events, and resources to njactscommunity@rwjms.rutgers.edu
Copyright 2021 New Jersey Alliance for Clinical and Translational Science, all rights reserved.
|
|
|
|
|
|
|
